Skip to Content


Active substance(s): TERIPARATIDE

PDF options:  View Fullscreen   Download PDF

PDF Transcript

Package leaflet: Information for the user
Teriparatide 20 micrograms/80 microlitres Solution for Injection in Pre-filled Pen
Read all of this leaflet carefully before you start using this medicine because it contains important
information for you.
Keep this leaflet. You may need to read it again.
If you have any further questions, ask your doctor or pharmacist.
This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if
their signs of illness are the same as yours.
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects
not listed in this leaflet. See section 4.
What is in this leaflet
What Teriparatide is and what it is used for
What you need to know before you use Teriparatide
How to use Teriparatide
Possible side effects
How to store Teriparatide
Content of the pack and other information


What Teriparatide is and what it is used for

Teriparatide contains the active substance teriparatide that is used to make the bones stronger, and to reduce
the risk of fractures by stimulating bone formation.
Teriparatide is used to treat osteoporosis in adults. Osteoporosis is a disease that causes your bones to
become thin and fragile. This disease is especially common in women after the menopause, but it can also
occur in men. Osteoporosis is also common in patients receiving corticosteroids.


What you need to know before you use Teriparatide

Do Not use Teriparatide :

if you are allergic to teriparatide or any of the other ingredients of this medicine (listed in section 6).

if you suffer from high calcium levels (pre-existing hypercalcaemia).

if you suffer from serious kidney problems.

if you have ever been diagnosed with bone cancer or other cancers that have spread (metastasised) to
your bones.

if you have certain bone diseases. If you have a bone disease, tell your doctor.

if you have unexplained high levels of alkaline phosphatase in your blood, which means you might
have Paget’s disease of bone (disease with abnormal bone changes).. If you are not sure, ask your

if you have had radiation therapy involving your bones.

if you are pregnant or breast-feeding.
Warnings and precautions
Teriparatide may cause an increase in the amount of calcium in your blood or urine.
Talk to your doctor or pharmacist before or while using Teriparatide :

if you have continuing nausea, vomiting, constipation, low energy, or muscle weakness. These may be
signs there is too much calcium in your blood.
if you suffer from kidney stones or have a history of kidney stones.
if you suffer from kidney problems (moderate renal impairment).

Some patients get dizzy or get a fast heartbeat after the first few doses. For the first doses, inject Teriparatide
where you can sit or lie down right away if you get dizzy.
The recommended treatment time of 24 months should not be exceeded.
Teriparatide should not be used in growing adults.
Children and adolescents
Teriparatide should not be used in children and adolescents (less than 18 years).
Other medicines and Teriparatide
Please tell your doctor or pharmacist if you are taking, have recently taken or might take any other
medicines, because occasionally they may interact (e.g. digoxin/digitalis, a medicine used to treat heart
Pregnancy, breast-feeding and fertility
Do not use Teriparatide if you are pregnant or breast-feeding. If you are a woman of child-bearing potential,
you should use effective methods of contraception during use of Teriparatide . If you become pregnant,
Teriparatide should be discontinued. Ask your doctor or pharmacist for advice before taking any medicine.
Driving and using machines
Some patients may feel dizzy after injecting Teriparatide . If you feel dizzy you should not drive or use
machines until you feel better.
Important information about some of the ingredients of Teriparatide :
This medicine contains less than 1 mmol sodium (23 mg) per dose. This means that it is essentially “sodiumfree”.


How to use Teriparatide

Always use this medicine exactly as your doctor has told you to. Check with your doctor or pharmacist if
you are not sure.
The recommended dose is 20 micrograms given once daily by injection under the skin (subcutaneous
injection) in the thigh or abdomen. To help you remember to take your medicine, inject it at about the same
time each day.
Inject Teriparatide each day for as long as your doctor prescribes it for you. The total duration of treatment
with Teriparatide should not exceed 24 months. You should not receive more than one treatment course of
24 months over your lifetime.
Teriparatide can be injected at meal times.
Read the user manual booklet, which is included in the carton for instructions on how to use the Teriparatide
Injection needles are not included with the pen. Becton, Dickinson and Company pen needles 29 to 31 gauge
(diameter 0.25-0.33 mm) and 12.7, 8 or 5 mm length can be used.
You should take your Teriparatide injection shortly after you take the pen out of the refrigerator as described
in the user manual. Put the pen back into the refrigerator immediately after you have used it.

Use a new injection needle for each injection and dispose of it after each use. Never store your pen with the
needle attached. Never share your Teriparatide pen with others.
Your doctor may advise you to take Teriparatide with calcium and vitamin D. Your doctor will tell you how
much you should take each day.
Teriparatide can be given with or without food.
If you use more Teriparatide than you should
If, by mistake, you have used more Teriparatide than you should, contact your doctor or pharmacist.
The effects of overdose that might be expected include nausea, vomiting, dizziness, and headache.
If you forget or cannot take Teriparatide at your usual time, take it as soon as possible on that day. Do
not take a double dose to make up for a forgotten dose. Do not take more than one injection in the same day.
Do not try to make up for a missed dose.
If you stop taking Teriparatide
If you are considering stopping Teriparatide treatment, please discuss this with your doctor. Your doctor
will advise you and decide how long you should be treated with Teriparatide .
If you have any further questions on the use of this medicine, ask your doctor or pharmacist.


Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.
The most common side effects are pain in limb (frequency is very common, may affect more than 1 in 10
people) and feeling sick, headache and dizziness (frequency is common).If you become dizzy (light-headed)
after your injection, you should sit or lie down until you feel better. If you do not feel better, you should call
a doctor before you continue treatment. Cases of fainting have been reported in association with teriparatide
If you experience discomfort such as redness of the skin, pain, swelling, itching, bruising or minor bleeding
around the area of the injection (frequency is common), this should clear up in a few days or weeks.
Otherwise tell your doctor as soon as possible.
Some patients may have experienced allergic reactions soon after injection, consisting of breathlessness,
swelling of the face, rash and chest pain (frequency is rare). In rare cases, serious and potentially lifethreatening allergic reactions including anaphylaxis can occur. . If you experience any of these symptoms,
STOP taking Teriparatide and contact your doctor IMMEDIATELY.
Other side effects include:
Common: may affect up to 1 in 10 people

increase in blood cholesterol levels


neuralgic pain in the leg

feeling faint

irregular heart beats


increased sweating

muscle cramps

loss of energy


chest pain • low blood pressure

heartburn (painful or burning sensation just below the breast bone)

being sick(vomiting)


a hernia of the tube that carries food to your stomach
low haemoglobin or red blood cell count (anaemia)

Uncommon: may affect up to 1 in 100 people

increased heart rate

abnormal heart sound

shortness of breath

haemorrhoids (piles)

accidental loss or leakage of urine

increased need to pass water

weight increase

kidney stones

pain in the muscles and pain in the joints. Some patients have experienced severe back cramps or pain
which lead to hospitalisation.

increase in blood calcium level

increase in blood uric acid level

increase in an enzyme called alkaline phosphatase.
Rare: may affect up to 1 in 1,000 people

reduced kidney function, including renal failure

swelling, mainly in the hands, feet and legs.
Reporting of side effects
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not
listed in this leaflet. You can also report side effects directly via the Yellow Card Scheme at: By reporting side effects you can help provide more information on the
safety of this medicine.
5. How to store Teriparatide
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the carton and pen after EXP. The expiry
date refers to the last day of that month.
Teriparatide should be stored in a refrigerator (2°C to 8°C) at all times. You can use Teriparatide for up to
28 days after the first injection, as long as the pen is stored in a refrigerator (2°C to 8°C).
Do not freeze Teriparatide . Avoid placing the pens close to the ice compartment of the refrigerator to
prevent freezing. Do not use Teriparatide if it is, or has been, frozen.
Each pen should be properly disposed of after 28 days, even if it is not completely empty.
Teriparatide contains a clear and colourless solution. Do not use Teriparatide if solid particles appear or if
the solution is cloudy or coloured.
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw
away medicines you no longer use These measures will help to protect the environment.
6. Contents of the pack and other information
What Teriparatide contains
The active substance is teriparatide. One pre-filled pen of 2.4 mL contains 600 micrograms of
teriparatide (corresponding to 250 micrograms per mL).


The other ingredients are glacial acetic acid, sodium acetate trihydrate, mannitol, metacresol, and
water for injections. In addition, hydrochloric acid and/or sodium hydroxide solution may have been
added for pH adjustment.

What Teriparatide looks like and contents of the pack
Teriparatide is a colourless and clear solution. It is supplied in a cartridge contained in a pre-filled
disposable pen. Each pen contains 2.4 mL of solution enough for 28 doses. The pens are available in cartons
containing one or three pens. Not all pack sizes may be available.
Marketing Authorisation Holder
TEVA UK Limited, Eastbourne, BN22 9AG, UK

TEVA Gyógyszergyár Zrt,
Gödöllő, Táncsics Mihály út 82,
Teva Pharma B.V.
Swensweg 5, Haarlem,
2031 GA,
The Netherlands
PLIVA Hrvatska d.o.o. (PLIVA Croatia Ltd.)
Prilaz baruna Filipovica 25, Zagreb ,
This leaflet was last revised in 10/2016
PL 00289/2005
*Only the actual site of batch release will appear on the printed version of the leaflet


+ Expand Transcript

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.